Artal Group S.A.
- SEC CIK
- 0001053906
- Latest filing
- Aug 13, 2026
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Nov 12, 2021. Long positions only; changes compare share counts with Q2 2021.
- Positions
- 140
- +2 vs. Q2 2021
- Portfolio value
- $4.07B
- −$328.3M (−7.5%) vs. Q2 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 71,178,364 | $342.4M | 8.4% | 00.0% | Unchanged | History |
| WWWW International, Inc. | COM | 14,818,300 | $270.4M | 6.7% | 00.0% | Unchanged | History |
| ONCBeOne Medicines Ltd. | ADR | 650,000 | $235.9M | 5.8% | −200,000−23.5% | Reduced | History |
| MRTXMirati Therapeutics, Inc. | COM | 1,200,000 | $212.3M | 5.2% | +350,000+41.2% | Added | History |
| ARGXArgenx SE | SPONSORED ADR | 577,308 | $174.3M | 4.3% | +77,308+15.5% | Added | History |
| XLRNAcceleron Pharma Inc | COM | 1,000,000 | $172.1M | 4.2% | −400,000−28.6% | Reduced | History |
| SEERSeer, Inc. | COM CL A | 4,750,000 | $164.0M | 4.0% | −838,366−15.0% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 700,000 | $132.2M | 3.3% | −50,000−6.7% | Reduced | History |
| MORFMorphic Holding, Inc. | COM | 1,585,049 | $89.8M | 2.2% | −234,137−12.9% | Reduced | History |
| IGMSIGM Biosciences, Inc. | COM | 1,350,000 | $88.8M | 2.2% | +250,000+22.7% | Added | History |
| FATEFate Therapeutics Inc | COM | 1,450,000 | $85.9M | 2.1% | +100,000+7.4% | Added | History |
| RUBYRubius Therapeutics, Inc. | COM | 4,155,625 | $74.3M | 1.8% | −478,166−10.3% | Reduced | History |
| GBIOGeneration Bio Co. | COM | 2,814,191 | $70.6M | 1.7% | 00.0% | Unchanged | History |
| ERASErasca, Inc. | COM | 3,172,221 | $67.3M | 1.7% | +3,172,221 | New | History |
| SRRKScholar Rock Holding Corp | COM | 1,950,000 | $64.4M | 1.6% | −50,000−2.5% | Reduced | History |
| FOLDAmicus Therapeutics, Inc. | COM | 6,696,955 | $64.0M | 1.6% | +2,946,955+78.6% | Added | History |
| SGENSeagen Inc. | COM | 375,000 | $63.7M | 1.6% | +375,000 | New | History |
| NBPNovaBridge Biosciences | SPONSORED ADS | 825,000 | $59.8M | 1.5% | +75,000+10.0% | Added | History |
| KLRSKalaris Therapeutics, Inc. | COM | 2,323,371 | $58.2M | 1.4% | 00.0% | Unchanged | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 1,800,000 | $53.1M | 1.3% | −200,000−10.0% | Reduced | History |
| CYTKCytokinetics Inc | COM NEW | 1,300,000 | $46.5M | 1.1% | +800,000+160.0% | Added | History |
| SAGESage Therapeutics, Inc. | COM | 1,000,000 | $44.3M | 1.1% | 00.0% | Unchanged | History |
| OMGAOmega Therapeutics, Inc. | COMMON STOCK | 2,273,530 | $42.9M | 1.1% | +2,273,530 | New | History |
| SDGRSchrodinger, Inc. | COM | 700,000 | $38.3M | 0.9% | −97,445−12.2% | Reduced | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 600,000 | $38.1M | 0.9% | +100,000+20.0% | Added | History |
| ALXOAlx Oncology Holdings Inc | COM | 500,000 | $36.9M | 0.9% | 00.0% | Unchanged | History |
| NTLAIntellia Therapeutics, Inc. | COM | 275,000 | $36.9M | 0.9% | +25,000+10.0% | Added | History |
| Bellus Health Inc New07987C204 | COM NEW | 5,250,000 | $32.2M | 0.8% | +500,000+10.5% | Added | – |
| GOSSGossamer Bio, Inc. | COM | 2,358,968 | $29.7M | 0.7% | 00.0% | Unchanged | History |
| AGENAgenus Inc | COM NEW | 5,500,000 | $28.9M | 0.7% | −500,000−8.3% | Reduced | History |
| TRMLTourmaline Bio, Inc. | COM | 2,064,262 | $28.0M | 0.7% | 00.0% | Unchanged | History |
| KRONKronos Bio, Inc. | COM | 1,317,954 | $27.6M | 0.7% | 00.0% | Unchanged | History |
| ATRAAtara Biotherapeutics, Inc. | COM | 1,500,000 | $26.9M | 0.7% | 00.0% | Unchanged | History |
| ITOSiTeos Therapeutics, Inc. | COM | 994,047 | $26.8M | 0.7% | 00.0% | Unchanged | History |
| REPLReplimune Group, Inc. | COM | 900,000 | $26.7M | 0.7% | 00.0% | Unchanged | History |
| TGTXTG Therapeutics, Inc. | COM | 800,000 | $26.6M | 0.7% | 00.0% | Unchanged | History |
| PTGXProtagonist Therapeutics, Inc | COM | 1,500,000 | $26.6M | 0.7% | +1,500,000 | New | History |
| KRYSKrystal Biotech, Inc. | COM | 500,000 | $26.1M | 0.6% | 00.0% | Unchanged | History |
| DNLIDenali Therapeutics Inc. | COM | 500,000 | $25.2M | 0.6% | 00.0% | Unchanged | History |
| FHTXFoghorn Therapeutics Inc. | COM | 1,720,720 | $24.0M | 0.6% | 00.0% | Unchanged | History |
| KYMRKymera Therapeutics, Inc. | COM | 400,000 | $23.5M | 0.6% | +150,000+60.0% | Added | History |
| TPTXTurning Point Therapeutics, Inc. | COM | 350,000 | $23.3M | 0.6% | 00.0% | Unchanged | History |
| FMTXForma Therapeutics Holdings, Inc. | SHS | 1,000,000 | $23.2M | 0.6% | 00.0% | Unchanged | History |
| SQZSQZ Biotechnologies Co | COM | 1,606,309 | $23.2M | 0.6% | 00.0% | Unchanged | History |
| OTLYOatly Group AB | SPONSORED ADS | 1,500,000 | $22.7M | 0.6% | 00.0% | Unchanged | History |
| PRAXPraxis Precision Medicines, Inc. | COM | 1,200,000 | $22.2M | 0.5% | 00.0% | Unchanged | History |
| AUPHAurinia Pharmaceuticals Inc. | COM | 1,000,000 | $22.1M | 0.5% | 00.0% | Unchanged | History |
| KURAKura Oncology, Inc. | COM | 1,050,000 | $19.7M | 0.5% | +450,000+75.0% | Added | History |
| IMAImageneBio, Inc. | COM | 1,549,513 | $19.6M | 0.5% | 00.0% | Unchanged | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 1,040,882 | $19.4M | 0.5% | 00.0% | Unchanged | History |
| VERVVerve Therapeutics, Inc. | COM | 400,000 | $18.8M | 0.5% | −100,000−20.0% | Reduced | History |
| ALBOAlbireo Pharma, Inc. | COM | 600,000 | $18.7M | 0.5% | 00.0% | Unchanged | History |
| NEXINexImmune, Inc. | COM | 1,200,000 | $18.2M | 0.4% | 00.0% | Unchanged | History |
| NGNovagold Resources Inc | COM NEW | 2,600,000 | $17.9M | 0.4% | 00.0% | Unchanged | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 2,255,375 | $17.6M | 0.4% | 00.0% | Unchanged | – |
| RNACCartesian Therapeutics, Inc. | COM | 4,000,000 | $16.6M | 0.4% | 00.0% | Unchanged | History |
| CYPHCypherpunk Technologies Inc. | COM | 4,000,000 | $16.0M | 0.4% | +1,000,000+33.3% | Added | History |
| BABAAlibaba Group Holding Ltd | ADR | 100,000 | $14.8M | 0.4% | +100,000 | New | History |
| RPTXRepare Therapeutics Inc. | COM | 550,000 | $14.4M | 0.4% | 00.0% | Unchanged | History |
| ADAGAdagene Inc. | ADS | 1,000,000 | $14.4M | 0.4% | 00.0% | Unchanged | History |
| APTXAptinyx Inc. | COM | 6,116,493 | $14.3M | 0.4% | 00.0% | Unchanged | History |
| DRNADicerna Pharmaceuticals Inc | COM | 700,000 | $14.1M | 0.3% | −100,000−12.5% | Reduced | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 1,646,517 | $13.9M | 0.3% | 00.0% | Unchanged | History |
| ZYMEZymeworks Inc. | COM | 450,000 | $13.1M | 0.3% | 00.0% | Unchanged | History |
| RLAYRelay Therapeutics, Inc. | COM | 400,000 | $12.6M | 0.3% | 00.0% | Unchanged | History |
| BBIOBridgeBio Pharma, Inc. | COM | 250,000 | $11.7M | 0.3% | −25,000−9.1% | Reduced | History |
| AMAMAmbrx Biopharma Cayman, Inc. | SPONSORED ADS | 850,000 | $11.5M | 0.3% | 00.0% | Unchanged | History |
| LENZLENZ Therapeutics, Inc. | COM | 700,000 | $11.5M | 0.3% | 00.0% | Unchanged | History |
| YMABY-mAbs Therapeutics, Inc. | COM | 400,000 | $11.4M | 0.3% | 00.0% | Unchanged | History |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 1,000,000 | $11.4M | 0.3% | 00.0% | Unchanged | History |
| NBTXNanobiotix S.A. | SPONSORED ADS | 1,000,000 | $11.4M | 0.3% | 00.0% | Unchanged | History |
| MRSNMersana Therapeutics, Inc. | COM | 1,200,000 | $11.3M | 0.3% | 00.0% | Unchanged | History |
| LYELLyell Immunopharma, Inc. | COM | 700,000 | $10.4M | 0.3% | 00.0% | Unchanged | History |
| BPMCBlueprint Medicines Corp | COM | 100,000 | $10.3M | 0.3% | 00.0% | Unchanged | History |
| CRISCuris Inc | COM NEW | 1,300,000 | $10.2M | 0.3% | 00.0% | Unchanged | History |
| CRBUCaribou Biosciences, Inc. | COM | 405,347 | $9.68M | 0.2% | +405,347 | New | History |
| SPROSpero Therapeutics, Inc. | COM | 500,000 | $9.21M | 0.2% | 00.0% | Unchanged | History |
| SANASana Biotechnology, Inc. | COM | 400,000 | $9.01M | 0.2% | 00.0% | Unchanged | History |
| SYRSSyros Pharmaceuticals, Inc. | COM | 2,000,000 | $8.94M | 0.2% | +300,000+17.6% | Added | History |
| VORVor Biopharma Inc. | COM | 550,000 | $8.62M | 0.2% | 00.0% | Unchanged | History |
| KRSAKorsana Biosciences, Inc. | COM | 2,779,122 | $8.53M | 0.2% | 00.0% | Unchanged | History |
| DYNDyne Therapeutics, Inc. | COM | 525,000 | $8.53M | 0.2% | 00.0% | Unchanged | History |
| OVIDOvid Therapeutics Inc. | COM | 2,500,000 | $8.40M | 0.2% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 400,000 | $8.36M | 0.2% | 00.0% | Unchanged | History |
| SYRESpyre Therapeutics, Inc. | COM | 1,045,000 | $8.31M | 0.2% | 00.0% | Unchanged | History |
| TILInstil Bio, Inc. | COM | 450,000 | $8.04M | 0.2% | 00.0% | Unchanged | History |
| IQiQIYI, Inc. | SPONSORED ADS | 1,000,000 | $8.03M | 0.2% | 00.0% | Unchanged | History |
| HARPHarpoon Therapeutics, Inc. | COM | 1,000,000 | $7.90M | 0.2% | 00.0% | Unchanged | History |
| IMCRImmunocore Holdings plc | ADS | 200,000 | $7.41M | 0.2% | 00.0% | Unchanged | History |
| Omega Alpha SpacG6749V107 | CL A | 750,000 | $7.30M | 0.2% | 00.0% | Unchanged | – |
| OLMAOlema Pharmaceuticals, Inc. | COM | 260,500 | $7.18M | 0.2% | 00.0% | Unchanged | History |
| SLDBSolid Biosciences Inc. | COM | 3,000,000 | $7.17M | 0.2% | +750,000+33.3% | Added | History |
| EVLOEvelo Biosciences, Inc. | COM | 1,000,000 | $7.04M | 0.2% | 00.0% | Unchanged | History |
| ACIUAC Immune SA | SHS | 1,000,000 | $6.71M | 0.2% | 00.0% | Unchanged | History |
| APLTApplied Therapeutics, Inc. | COM | 400,000 | $6.64M | 0.2% | 00.0% | Unchanged | History |
| ADVMAdverum Biotechnologies, Inc. | COM | 3,000,000 | $6.51M | 0.2% | 00.0% | Unchanged | History |
| TCRRTCR2 Therapeutics Inc. | COM | 750,000 | $6.38M | 0.2% | 00.0% | Unchanged | History |
| STOKStoke Therapeutics, Inc. | COM | 250,000 | $6.36M | 0.2% | 00.0% | Unchanged | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 593,030 | $6.33M | 0.2% | 00.0% | Unchanged | History |
| IMUXImmunic, Inc. | COM | 700,000 | $6.20M | 0.2% | 00.0% | Unchanged | History |
Options (6)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q2 2021 (15)
Positions held at the end of Q2 2021 that are gone from this filing.
| Security | Class | Shares in Q2 2021 | Value in Q2 2021 | % of portfolio in Q2 2021 | History |
|---|---|---|---|---|---|
| BHVNBiohaven Ltd. | COM | 400,000 | $38.8M | 0.9% | History |
| Trillium Therapeutics Inc.89620X506 | COM NEW | 2,500,000 | $24.3M | 0.6% | – |
| CARAvis Budget Group, Inc. | COM | 300,000 | $23.4M | 0.5% | History |
| DLOdLocal Ltd | CLASS A COM | 295,000 | $15.5M | 0.4% | History |
| LFSTLifeStance Health Group, Inc. | COM | 500,000 | $13.9M | 0.3% | History |
| Translate Bio, Inc.89374L104 | COM | 500,000 | $13.8M | 0.3% | – |
| AGLagilon health, inc. | COM | 300,000 | $12.2M | 0.3% | History |
| NEUENeueHealth, Inc. | COM | 305,555 | $5.24M | 0.1% | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 431,894 | $4.89M | 0.1% | History |
| MCRBSeres Therapeutics, Inc. | COM | 200,000 | $4.77M | 0.1% | History |
| Paramount Global92556H206 | CL B | 75,000 | $3.39M | 0.1% | – |
| MOLNMolecular Partners AG | ADS | 100,000 | $2.05M | <0.1% | History |
| Chiasma, Inc16706W102 | COM | 380,000 | $1.80M | <0.1% | – |
| Cerevel Therapeutics HLDNG I15678U102 | *W EXP 06/09/202 | 79,600 | $1.15M | <0.1% | – |
| LULufax Holding Ltd | ADS REP SHS CL A | 50,000 | $565.0K | <0.1% | History |